HUB Organoids predict patient response to treatment.
Our technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.
Reduce drug attrition and predict patient response with our preclinical services and clinical trials in a dish
Decipher the complexity of the human disease with our custom model and assay development services
1000s of established models – from both normal and diseased tissue
Bring HUB Organoid Technology and knowhow in-house
by bringing next-generation therapeutics to patients
Outsource your drug development program
NEWS AND INSIGHTS